NCT00893256View on ClinicalTrials.gov

Effect of Add-on Citalopram to Risperidone on Negative Symptoms in Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
SchizophreniaNegative Symptoms
Interventions
DRUG

Risperidone

Risperidone: tablet; oral; 4-6 mg/day; once daily; 12 weeks

DRUG

risperidone

Risperidone: tablet; 4-8 mg/day; once daily; 12 weeks

DRUG

Citalopram

Citalopram: tablet; oral; 20 mg/day; once daily; 12 weeks

DRUG

Placebo

Placebo: once daily

Trial Locations (1)

560 029

National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore

All Listed Sponsors
lead

National Institute of Mental Health and Neuro Sciences, India

OTHER

NCT00893256 - Effect of Add-on Citalopram to Risperidone on Negative Symptoms in Schizophrenia | Biotech Hunter | Biotech Hunter